TipRanks
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market
2162
Keymed Biosciences, Inc.
RESEARCH TOOLSreports
Want to see HK:2162 full AI Analyst Report?

Keymed Biosciences, Inc. (2162) Ratios

1 Followers

Keymed Biosciences, Inc. Ratios

HK:2162's free cash flow for Q2 2026 was ¥0.74. For the 2026 fiscal year, HK:2162's free cash flow was decreased by ¥ and operating cash flow was ¥-0.23. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.83 2.90 3.30 9.36 8.72
Quick Ratio
 4.55 2.66 3.15 9.16 8.60
Cash Ratio
 2.88 0.65 0.56 2.71 1.59
Solvency Ratio
 0.51 -0.29 -0.36 -0.32 -0.46
Operating Cash Flow Ratio
 -0.73 -0.85 -1.06 -0.97 -1.06
Short-Term Operating Cash Flow Coverage
 -1.40 -1.40 -1.67 -6.63 -6.57
Net Current Asset Value
¥ 2.28B¥ 980.65M¥ 1.17B¥ 2.04B¥ 2.72B
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.19 0.20 0.11 0.03
Debt-to-Equity Ratio
 0.17 0.28 0.30 0.14 0.04
Debt-to-Capital Ratio
 0.15 0.22 0.23 0.12 0.04
Long-Term Debt-to-Capital Ratio
 0.06 0.09 0.09 0.10 <0.01
Financial Leverage Ratio
 1.42 1.52 1.52 1.30 1.18
Debt Service Coverage Ratio
 -1.83 -0.93 -1.18 -4.30 -3.74
Interest Coverage Ratio
 -39.41 -35.51 -33.48 -25.19 -66.16
Debt to Market Cap
 0.03 0.06 0.10 0.03 <0.01
Interest Debt Per Share
 2.51 2.94 2.95 1.67 0.50
Net Debt to EBITDA
 3.17 -0.50 -0.58 1.60 1.86
Profitability Margins
Gross Profit Margin
68.24%74.02%97.15%89.59%97.42%
EBIT Margin
-74.63%-83.82%-146.24%-95.72%-295.19%
EBITDA Margin
-63.64%-70.13%-134.18%-76.19%-259.09%
Operating Profit Margin
-74.63%-83.82%-144.37%-122.79%-543.47%
Pretax Profit Margin
127.58%-72.69%-118.81%-100.59%-303.41%
Net Profit Margin
92.92%-72.96%-120.35%-101.49%-307.92%
Continuous Operations Profit Margin
92.94%-72.96%-120.27%-101.04%-303.41%
Net Income Per EBT
72.83%100.37%101.30%100.89%101.49%
EBT Per EBIT
-170.95%86.73%82.29%81.92%55.83%
Return on Assets (ROA)
13.48%-12.07%-13.68%-9.25%-7.84%
Return on Equity (ROE)
22.54%-18.34%-20.82%-12.03%-9.22%
Return on Capital Employed (ROCE)
-12.65%-17.29%-20.47%-12.18%-15.31%
Return on Invested Capital (ROIC)
-8.46%-14.99%-17.64%-11.96%-15.00%
Return on Tangible Assets
13.51%-12.09%-13.71%-9.26%-7.84%
Earnings Yield
4.00%-3.87%-6.78%-3.09%-2.62%
Efficiency Ratios
Receivables Turnover
 3.91 6.92 6.57 11.63 208.46
Payables Turnover
 5.17 6.46 0.47 1.25 0.17
Inventory Turnover
 1.13 0.92 0.11 0.60 0.06
Fixed Asset Turnover
 0.60 0.54 0.41 0.40 0.17
Asset Turnover
 0.15 0.17 0.11 0.09 0.03
Working Capital Turnover Ratio
 0.35 0.42 0.20 0.13 0.03
Cash Conversion Cycle
 344.49 391.06 2.61K 344.27 4.18K
Days of Sales Outstanding
 93.30 52.78 55.52 31.38 1.75
Days of Inventory Outstanding
 321.76 394.80 3.33K 604.75 6.28K
Days of Payables Outstanding
 70.57 56.52 778.08 291.86 2.11K
Operating Cycle
 415.05 447.58 3.39K 636.13 6.28K
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.10 -2.60 -3.01 -1.16 -1.54
Free Cash Flow Per Share
 -3.02 -3.83 -3.83 -2.63 -2.61
CapEx Per Share
 0.92 1.23 0.82 1.46 1.07
Free Cash Flow to Operating Cash Flow
 1.44 1.47 1.27 2.26 1.70
Dividend Paid and CapEx Coverage Ratio
 -2.29 -2.12 -3.68 -0.79 -1.44
Capital Expenditure Coverage Ratio
 -2.29 -2.12 -3.68 -0.79 -1.44
Operating Cash Flow Coverage Ratio
 -0.86 -0.90 -1.05 -0.73 -3.30
Operating Cash Flow to Sales Ratio
 -0.73 -1.02 -1.84 -0.86 -4.02
Free Cash Flow Yield
-4.32%-7.97%-13.21%-5.90%-5.80%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 24.22 -25.81 -14.75 -32.36 -38.17
Price-to-Sales (P/S) Ratio
 24.12 18.85 17.76 32.84 117.52
Price-to-Book (P/B) Ratio
 4.77 4.74 3.07 3.89 3.52
Price-to-Free Cash Flow (P/FCF) Ratio
 -23.13 -12.54 -7.57 -16.94 -17.26
Price-to-Operating Cash Flow Ratio
 -31.99 -18.46 -9.63 -38.30 -29.26
Price-to-Earnings Growth (PEG) Ratio
 -0.90 4.62 -0.34 -2.01 0.40
Price-to-Fair Value
 4.77 4.74 3.07 3.89 3.52
Enterprise Value Multiple
 -34.73 -27.38 -13.82 -41.50 -43.50
Enterprise Value
 18.18B 13.40B 7.94B 11.20B 11.28B
EV to EBITDA
 -34.73 -27.38 -13.82 -41.50 -43.50
EV to Sales
 22.10 19.20 18.54 31.62 112.70
EV to Free Cash Flow
 -21.20 -12.77 -7.90 -16.31 -16.55
EV to Operating Cash Flow
 -30.47 -18.81 -10.05 -36.87 -28.06
Tangible Book Value Per Share
 14.10 10.10 9.41 11.42 12.78
Shareholders’ Equity Per Share
 14.13 10.13 9.45 11.43 12.79
Tax and Other Ratios
Effective Tax Rate
 0.27 >-0.01 -0.01 >-0.01 0.00
Revenue Per Share
 2.90 2.55 1.63 1.35 0.38
Net Income Per Share
 2.70 -1.86 -1.97 -1.37 -1.18
Tax Burden
 0.73 1.00 1.01 1.01 1.01
Interest Burden
 -1.71 0.87 0.81 1.05 1.03
Research & Development to Revenue
 0.84 1.01 1.72 1.68 5.07
SG&A to Revenue
 0.59 0.57 0.70 0.50 1.34
Stock-Based Compensation to Revenue
 0.00 0.04 0.08 0.11 0.49
Income Quality
 -0.76 1.37 1.55 0.85 1.32
Currency in CNY